Home Healthcare Medical Devices Pain Management Devices Market

Pain Management Devices Market Size, Share & Trends Analysis Report By Type (Neuromodulation and neurostimulation devices, Analgesic infusion pumps, Ablation devices), By Applications (Cancer pain, Neuropathic pain, Facial and migraine pain, Musculoskeletal pain, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Pain Management Devices Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Neuromodulation and neurostimulation devices
    2. Analgesic infusion pumps
    3. Ablation devices
  2. Pain Management Devices Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Cancer pain
    2. Neuropathic pain
    3. Facial and migraine pain
    4. Musculoskeletal pain
    5. Others
  3. Regional Pain Management Devices Market
    1. North America
      1. North America Pain Management Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
      2. North America Pain Management Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cancer pain
        2. Neuropathic pain
        3. Facial and migraine pain
        4. Musculoskeletal pain
        5. Others
      3. U.S.
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      4. Canada
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
    2. Europe
      1. Europe Pain Management Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
      2. Europe Pain Management Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cancer pain
        2. Neuropathic pain
        3. Facial and migraine pain
        4. Musculoskeletal pain
        5. Others
      3. U.K.
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      4. Germany
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      5. France
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      6. Spain
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      7. Italy
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      8. Russia
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      9. Nordic
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      10. Benelux
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      11. Rest of Europe
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
    3. APAC
      1. APAC Pain Management Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
      2. APAC Pain Management Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cancer pain
        2. Neuropathic pain
        3. Facial and migraine pain
        4. Musculoskeletal pain
        5. Others
      3. China
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      4. Korea
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      5. Japan
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      6. India
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      7. Australia
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      8. Singapore
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      9. Taiwan
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      10. South East Asia
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      11. Rest of Asia-Pacific
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
    4. Middle East and Africa
      1. Middle East and Africa Pain Management Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
      2. Middle East and Africa Pain Management Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cancer pain
        2. Neuropathic pain
        3. Facial and migraine pain
        4. Musculoskeletal pain
        5. Others
      3. UAE
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      4. Turkey
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      5. Saudi Arabia
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      6. South Africa
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      7. Egypt
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      8. Nigeria
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      9. Rest of MEA
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
    5. LATAM
      1. LATAM Pain Management Devices Market By Type 2022-2034 (USD MILLION/ Units)
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
      2. LATAM Pain Management Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Cancer pain
        2. Neuropathic pain
        3. Facial and migraine pain
        4. Musculoskeletal pain
        5. Others
      3. Brazil
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      4. Mexico
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      5. Argentina
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      6. Chile
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      7. Colombia
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
      8. Rest of LATAM
        1. Neuromodulation and neurostimulation devices
        2. Analgesic infusion pumps
        3. Ablation devices
        4. Cancer pain
        5. Neuropathic pain
        6. Facial and migraine pain
        7. Musculoskeletal pain
        8. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.